Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$514M |
| 2 |
AGN
Allergan plc
AGN
|
+$364M |
| 3 |
Medtronic
MDT
|
+$323M |
| 4 |
Gilead Sciences
GILD
|
+$299M |
| 5 |
TripAdvisor
TRIP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 2 |
AGN
Allergan Inc
AGN
|
+$795M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$525M |
| 4 |
Apple
AAPL
|
+$473M |
| 5 |
Microsoft
MSFT
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Healthcare | 14.43% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
KB Home
KBH
$3.44B
| $17.5M | ﹤0.01% |
1,120,811
+21,135
| +2% | +$295K |
|
|
MDCO
1602
DELISTED
Medicines Co
MDCO
| $17.5M | ﹤0.01% |
623,689
-249,554
| -29% | -$7.01M |
|
1603
TotalEnergies
TTE
$196B
| $17.4M | ﹤0.01% |
222,579,946,556
-33,939,097,790
| -13% | -$3.39M |
|
1604
CDW
CDW
$17.4B
| $17.4M | ﹤0.01% |
467,592
+19,390
| +4% | +$706K |
|
1605
Neurocrine Biosciences
NBIX
$15.5B
| $17.3M | ﹤0.01% |
436,911
+48,703
| +13% | +$1.74M |
|
|
MFA
1606
MFA Financial
MFA
$926M
| $17.3M | ﹤0.01% |
550,857
+9,109
| +2% | +$288K |
|
|
WIRE
1607
DELISTED
Encore Wire Corp
WIRE
| $17.3M | ﹤0.01% |
456,953
+88,528
| +24% | +$3.04M |
|
1608
Brady Corp
BRC
$4.44B
| $17.3M | ﹤0.01% |
610,903
+3,552
| +0.6% | +$96.7K |
|
1609
iShares MSCI Taiwan ETF
EWT
$11.5B
| $17.3M | ﹤0.01% |
548,387
+2,934
| +0.5% | +$91.5K |
|
|
DWA
1610
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $17.2M | ﹤0.01% |
708,944
-887,966
| -56% | -$18.9M |
|
1611
Stagwell
STGW
$2.23B
| $17.1M | ﹤0.01% |
604,060
+298,930
| +98% | +$7.54M |
|
|
SHLM
1612
DELISTED
Schulman (A.) Inc
SHLM
| $17.1M | ﹤0.01% |
355,065
+4,622
| +1% | +$183K |
|
|
MFRM
1613
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $17.1M | ﹤0.01% |
245,740
+18,367
| +8% | +$1.13M |
|
1614
Sinclair Inc
SBGI
$1.07B
| $17.1M | ﹤0.01% |
542,970
+18,875
| +4% | +$513K |
|
1615
CONMED
CNMD
$1.51B
| $17M | ﹤0.01% |
337,543
-102,547
| -23% | -$5.03M |
|
1616
Visteon
VC
$2.89B
| $17M | ﹤0.01% |
176,242
-92,958
| -35% | -$9.28M |
|
|
COBZ
1617
DELISTED
CoBiz Financial,Inc
COBZ
| $17M | ﹤0.01% |
1,377,021
-99,380
| -7% | -$1.17M |
|
1618
Benchmark Electronics
BHE
$2.94B
| $16.9M | ﹤0.01% |
703,851
+37,873
| +6% | +$904K |
|
1619
Chord Energy
CHRD
$7.51B
| $16.9M | ﹤0.01% |
1,189,059
+486,215
| +69% | +$7.14M |
|
1620
Independent Bank
INDB
$4.07B
| $16.9M | ﹤0.01% |
384,618
+40,451
| +12% | +$1.66M |
|
|
MASI
1621
DELISTED
Masimo
MASI
| $16.8M | ﹤0.01% |
510,849
-212,476
| -29% | -$6.11M |
|
1622
Assured Guaranty
AGO
$3.38B
| $16.8M | ﹤0.01% |
635,101
-9,716
| -2% | -$251K |
|
1623
AMN Healthcare
AMN
$1.34B
| $16.7M | ﹤0.01% |
725,896
+249,561
| +52% | +$5.16M |
|
1624
PDF Solutions
PDFS
$2.15B
| $16.7M | ﹤0.01% |
933,537
+581,206
| +165% | +$10.1M |
|
1625
MGIC Investment
MTG
$6.39B
| $16.7M | ﹤0.01% |
1,736,541
-20,678
| -1% | -$189K |
|
Similar funds
Bank of New York Mellon's Q1 2015 Portfolio in Review
As of Q1 2015, Bank of New York Mellon held 4,377 positions worth $385B, up 0.54% from $383B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q1 2015 filing shows 128 new, 2,179 increased, 1,685 reduced and 142 closed positions. Its largest new stake was Qorvo: 1,775,142 shares worth $141M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.01B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2015 buy was Qorvo: 1,775,142 shares worth $141M.
- Bank of New York Mellon added most to Cognizant in Q1 2015, an estimated $514M increase.
- Bank of New York Mellon's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.01B.
- Bank of New York Mellon fully exited Allergan Inc in Q1 2015, selling an estimated $795M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $385B portfolio in Q1 2015.
- Bank of New York Mellon opened 128 new positions and closed 142 in Q1 2015.
- Bank of New York Mellon's portfolio value rose 0.54% quarter-over-quarter to $385B.
Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.